|
|
|
Insider
Information: |
Domain Parters Vii L P |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
24,239,056 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$381,684,788 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
24,239,056 |
|
|
Total
Value |
$381,684,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2011-12-22 |
2,967,415 |
2008-12-09 |
0 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-03-19 |
0 |
|
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2011-09-16 |
9,923,335 |
2010-11-29 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
2,990,937 |
2011-11-21 |
0 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
2013-07-01 |
2,066,935 |
2013-07-01 |
0 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
2013-09-30 |
1,114,327 |
2013-09-30 |
0 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
3,189,058 |
2013-11-19 |
0 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
1,987,049 |
2014-03-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2014-03-19 |
4 |
D |
$14.00 |
$41,617,492 |
D/D |
(2,972,678) |
0 |
0 |
- |
|
AKAO |
Achaogen Inc |
10% Owner |
|
2014-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,987,049 |
1,987,049 |
0 |
- |
|
TNDM |
Tandem Diabetes Care Inc |
10% Owner |
|
2013-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,189,058 |
3,189,058 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,114,327 |
1,114,327 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
B |
$14.00 |
$3,932,922 |
D/D |
280,923 |
2,066,935 |
2.45 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,786,012 |
1,786,012 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2011-12-22 |
4 |
B |
$1.45 |
$668,834 |
D/D |
461,265 |
2,967,415 |
2.45 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074,879 |
2,074,879 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2011-11-21 |
4 |
B |
$13.00 |
$11,908,754 |
D/D |
916,058 |
2,990,937 |
2.45 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$6,882,608 |
D/D |
3,441,304 |
9,923,335 |
2.45 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$9,242,356 |
D/D |
2,310,589 |
6,482,031 |
2.45 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,171,442 |
4,171,442 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-18 |
4 |
B |
$7.50 |
$280,958 |
D/D |
37,461 |
2,506,150 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-17 |
4 |
B |
$7.55 |
$742,339 |
D/D |
98,323 |
2,468,689 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-24 |
4 |
B |
$6.75 |
$331,837 |
D/D |
49,161 |
2,370,366 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$1,022,064 |
D/D |
147,484 |
2,321,205 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$1,703,449 |
D/D |
245,808 |
2,173,721 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-12 |
4 |
B |
$6.90 |
$420,624 |
D/D |
60,960 |
1,927,913 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-11 |
4 |
B |
$6.93 |
$365,218 |
D/D |
52,701 |
1,866,953 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-10 |
4 |
B |
$6.93 |
$575,086 |
D/D |
82,985 |
1,814,252 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-17 |
4 |
B |
$7.64 |
$474,757 |
D/D |
62,141 |
1,717,714 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-14 |
4 |
B |
$8.00 |
$206,280 |
D/D |
25,785 |
1,655,573 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-13 |
4 |
B |
$7.85 |
$100,339 |
D/D |
12,782 |
1,629,788 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-12 |
4 |
B |
$8.00 |
$3,146,336 |
D/D |
393,292 |
1,617,006 |
2.45 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-11 |
4 |
B |
$7.60 |
$779,388 |
D/D |
102,551 |
1,223,714 |
2.45 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|